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Bio-imaging and therapeutic nanoparticles-initially two different research
areas tend more and more to merge. The outcome? Highly sophisticated
imaging techniques offering new insights in nature or reducing side-effects
of clinical therapies-a perfect symbiosis. This symbiosis is reflected in
large improvements of medical diagnostics and therapy and even led to the
formation of a completely new approach named “theranostics”, the fusion
of the two areas therapeutics and diagnostics. Imaging of biological tissue
dates back to 1900’s. The X-ray illumination of the hand of Wilhelm
Roentgen's wife in 1895 was the first medical image exposing the unseen
world inside the living body. In parallel, the synthesis, characterization and
use of nanoparticles advanced leading inescapably to the idea to combine
both fields. If nanoparticles can be used to specifically deliver drugs to
target tissues why shouldn´t they transport e.g. contrast agents necessary
for clinical imaging?
Imaging-based diagnostics are an important tool in modern medicine. The
detection limit could be shifted widely downwards through nanoparticle
(nanoparticles)-assisted bio-imaging, thus realizing very early detection of
diseases such as cancer. Thanks to nanoparticles highly effective bio-
imaging techniques now allow for detection of very small tumor entities
that otherwise would have been overlooked; one major contributor to a
reduction in mortality of patients. These nanoparticles have many
advantages including real time monitoring, minimal or no invasiveness,
accessibility without tissue destruction and can be functionalized to take
effect over a wide range of time (from milliseconds to years) and size
scales (from molecular level to the whole organism) involved in the
imaging processes [1]. Depending on the imaging technique used, it can be
e.g. magnetic/metallic nanoparticles (magnetic resonance imaging [2,3],
in-vivo stem cell tracking [4]), reporter dyes/fluorophores in the nanoscale
(immunoassays [5], in-vivo fluorescent imaging [6], in-vivo stem cell
tracking [4]), radiolabeled nanoparticles (positron emission tomography,
single-photon emission computed tomography, Cerenkov luminescence
[7]) and so on.
Besides diagnostics, nanoparticles can also be used for therapy. Specific
targeting is of utmost importance in order to avoid or reduce side-effects of
toxic drugs or procedures. In the context of nano-bio-imaging this means,
that nanoparticles are used to render non-specific treatments specific and
thus highly effective and less destructive, e.g. photodynamic and
photothermal therapy are much better tolerated by patients when the
required photosensitizers (and oxygen in case of photodynamic therapy)
are delivered very locally to the target tissue; managed by their
incorporation in nanoparticles [8]. Not until with the aid of nanoparticles it
is possible to generate noxious reactive oxygen just exactly where they are
needed inducing oxidative stress or creating cell-hostile hyperthermia only
locally [8].
Beyond all the named improvements due to fusion of nano-research and
bio-imaging the most exciting actual development is the emergence of a
new approach called “theranostics”. As already visible by this portmanteau
word, therapeutic and diagnostic qualities are combined in nanoparticles
with multimodal functions. Among them also nanoparticles designed to
visualize and additionally destroy cancer tissue. Recent examples are
magnetic resonance imaging-guided photothermal or photodynamic
therapy by gadolinium oxide/chlorine e6 loaded nanoparticles
(Gd2O3@BSA conjugating Cle6) [9] or (even one step further) the
combination of fluorescence imaging, photothermal therapy and
chemotherapy realized by indocyanine green/ paclitaxel-loaded
nanoparticles (HSA-PTX-ICG nanoparticles) [9].
Only the combination of bio-imaging with nanoscience led to this success.
The tremendous improvement of all these imaging techniques is crucial to
guarantee the best possible outcome of the patient. To underline the
importance of this new field we launched this special issue of the Journal
of Nanoscience and Nanomedicine. We believe that the development in
this new field will guide earlier detection and thus permit earlier treatment
for human diseases.
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